Abstract
Interruption of pregnancy applies to gravidae at less than 28 full weeks’ gestation with a quiescent uterus. Practically, in the overwhelming majority of cases, abortion should be performed prior to viability or at less than 22 weeks’ gestation.
This is a preview of subscription content, log in via an institution.
Preview
Unable to display preview. Download preview PDF.
References
Amy, J. J., Thiery, M., Bygdeman, M., Kerenyi, T. D., Crawford, J. S. and Karim, S. M. M. (1976). A suggested set of working definitions and criteria applicable to interruption of pregnancy. Contraception, 14, 193–7
Baulieu, E. E. (1985). RU 486: An antiprogestin steroid with contragestive activity in women. In Baulieu, E. E. and Segal, S. J. (Eds.), The Antiprogestin Steroid RU 486 and Human Fertility Controls. Plenum Press, New York, pp. 1–25
Brenner, W. E. (1972). Second trimester interruption of pregnancy. In Taymor, M. K. and Green T. H. (Eds.), Progress in Gynecology, Vol. 6. Grune and Stratton, New York, pp. 421–44
Brenner, W. E. (1975). The current status of prostaglandins as abortifacients. Am. J. Obstet. Gynecol., 123, 306–28
Bygdeman, M. (1978). Comparison of prostaglandin and hypertonic saline for termination of pregnancy. Obstet. Gynecol., 52, 424–9
Bygdeman, M. (1984). The use of prostaglandins and their analogues for abortion. In Newton, J. R. (Ed.), Clinics in Obstetrics and Gynaecology, Vol. 11. W. B. Saunders, London, pp. 573–84
Bygdeman, M., Borell, U., Leader, A., Lundström, V., Martin, J. N., Jr., Eneroth, P. and Gréen, K. (1976). Induction of first and second trimester abortion by the vaginal administration of 15-methyl PGF2α methyl ester. In Samuelsson, B. and Paoletti, R. (Eds.), Advances in Prostaglandin and Thromboxane Research, Vol. 2. Raven Press, New York, pp. 693–704
Bygdeman, M., Christensen, N. J., Gréen, K. and Vesterqvist, O. (1984). Seifadministration at home of prostaglandin for termination of early pregnancy. In Toppozada, M., Bygdeman, M. and Hafez, E. S. E. (Eds.), Prostaglandins and Fertility Regulation. MTP, Lancaster, pp. 83–90
Bygdeman, M. and Swahn, M. L. (1985). Progesterone receptor blockage. Effect on uterine contractility in early pregnancy. Contraception, 32, 45–51
Bygdeman, M. and Van Look, P. F. A. (1988). Antiprogestins for the interruption of pregnancy. In Healy, D. L. (Ed.), Ballière’s Clinical Obstetrics and Gynaecology. Anti-hormones in Clinical Gynaecology. Ballière Tindall, London, pp. 617–29
Christensen, N. J., Belfrage, P., Bygdeman, M., Floberg, J., Mitzuhashi, N. and Gréen, K. (1985). Bioconversion of arachidonic acid in human pregnant uterine cervix. Acta Obstet. Gynecol. Scand., 64, 259–65
Chwalisz, K., Qing, S. S., Neef, G. and Elger, W. (1987). The effect of the antigestagen ZK 98,299 on the uterine cervix. Acta Endocrinol., 283 (Suppl.), 113–14
Edelman, D. A., Brenner, W. E. and Berger, G. B. (1974). Effectiveness and complication of abortion by dilatation and vacuum aspiration versus dilatation and rigid metal curettage. Am. J. Obstet. Gynecol., 119, 473–80
Galen, R. S., Chauhan, P., Wietzner, H. and Navarro, C. (1974). Fetal pathology and mechanism of fetal death in saline induced abortion: a study of 143 gestations and critical review of the literature. Am. J. Obstet. Gynecol., 12, 347–55
Gréen, K., Bygdeman, M. and Wiqvist, N. (1974). Kinetic and metabolic studies of prostaglandin F2α administered intra-amniotically for induction of abortion. Life Sci., 14, 2285–97
Gréen, K., Christensen, N. and Bygdeman, M. (1981). The chemistry and pharmacology of prostaglandins with reference to human reproduction. J. Reprod. Fertil., 62, 269–81
Gréen, K., Granström, E., Bygdeman, M. and Wiqvist, N. (1976). Kinetic and mrtabolic studies of 15-methyl PF2α administered intra-amniotically for induction of abortion. Prostaglandins, 11, 699–711
Gustavii, B. and Gréen, K. (1972). Release of prostaglandin F2α following injection of hypertonic saline for therapeutic abortion. A preliminary study. Am. J. Obstet. Gynecol., 114, 1099–100
Hulka, J. F., Leffler, H. T., Jr., Anglone, A. and Lachenbruch, P. A. (1974). A new electronic force monitor to measure factors influencing cervical dilatation for vacuum curettage. Am. J. Obstet. Gynecol., 120, 166–73
Kelly, R. W., Healy, D. L., Cameron, I. and Baird, D. T. (1986). The stimulation of prostaglandin production by two antiprogesterone steroids in human endometrial cells. J. Clin. Endocrinol. Metab., 62, 1117–23
Kerenyi, T. D. (1972). Technique of late abortion. In Lewit, S. (Ed.), Abortion Techniques and Services. Excerpta Medica, Amsterdam, pp. 17–22
Mandelin, M. (1978). Termination of early pregnancy by a single dose 3.0 mg 15-methyl PGF2α methyl ester vaginal suppository. Prostaglandins, 16, 143–51
Newton, J., Barnard, G. and Collons, W. (1977). A rapid method for measuring blood loss using autonomic extraction. Contraception, 16, 269–82
Ölund, A. (1978). The effect of indomethacin on the instillation-abortion interval in Rivanol-induced mid-trimester abortion. Acta Obstet. Gynecol. Scand., 57, 333–6
Ott, E. R. (1977). Cervical dilatation—A review. Population Reports, Series F, No. 6
Rådestad, A., Christensen, N. J. and Strömberg, L. (1988). Cervical ripening with Mifepristone in first trimester abortion. A double-blind randomized biomechanical study. Contraception, 38, 301–12
Rodger, M. W. and Baird, D. T. (1987). Induction of therapeutic abortion in early pregnancy with mifepristone in combination with prostaglandin pessary. Lancet, ii, 1415–18
Rooks, J. B. and Cates, W., Jr. (1977). Emotional impact of D&E vs. instillation. Fam. Plann. Perspect., 9, 276–7
Rosén, A.-S., Nystedt, L., Bygdeman, M. and Lundström, V. (1979). Acceptability of a non-surgical method to terminate very early pregnancy in comparison to vacuum aspiration. Contraception, 19, 107–17
Rosén, A.-S., von Knorring, K., Bygdeman, M. and Christensen, N. (1984). Randomized comparison of prostaglandin treatment in hospital or at home with vacuum aspiration for termination of early pregnancy. Contraception, 29, 423–35
Swahn, M. L. and Bygdeman, M. (1988). The effect of the antiprogestin RU 486 on uterine contractility and sensitivity to prostaglandin and oxytocin. Br. J. Obstet. Gynaecol., 95, 126–34
Swahn, M. L., Ugocsai, G., Bygdeman, M., Kovacs, L., Belsey, E. M. and Van Look, P. F. A. (1989). Effect of oral prostaglandins E2 on uterine contractility and treatment outcome in women receiving RU 486 (mifepristone) for termination of early pregnancy. Hum. Reprod., 4, 21
Tietze, C. and Henshaw, S. K. (1986). Induced Abortion: A World Review 1986. Alan Guttmacher Institute, New York and Washington
Tietze, C. and Lewit, S. (1972). Joint program for the study of gestation (JPSA). Early medical complications of legal abortion. Stud. Fam. Plann., 3, 97
Toppozada, M., Beguin, F., Bygdeman, M. and Wiqvist, N. (1972). Response of the midpregnant human uterus to systemic administration of 15(S)15-methyl prostaglandin F2α. Prostaglandins, 2, 239–49
Uldbjerg, N., Ulmsten, U. and Ekman, G. (1987). The physiological role of eicosanoids in controlling the form and function of the cervix. In Hillier, K. (Ed.), Advances in Eicosanoid Research. MTP, Lancaster, pp. 163–83
Waltman, R., Tricorni, V. and Palay, A. (1973). Aspirin and indomethacin: Effect on instillation/abortion time of mid-trimester hypertonic saline induced abortion. Prostaglandins, 3, 47–58
Van Look, P. F. A. (1989). Antiprogestin: a new era in hormonal regulation of fertility. In Proceedings of the First Congress of the International Society of Gynecological Endocrinology. Parthenon Publishing, Carnforth (in press)
WHO Task Force on Post-ovulatory Methods for Fertility Regulation (1987). Menstrual regulation by intramuscular injection of 16-phenoxy-tetranor PGE2 methyl sulfonylamide or vacuum aspiration. A randomized multicenter study. Br. J. Obstet. Gynaecol., 94, 949–56
Zuspan, F. P., Ballard, C. A., Bieniarz, J., Brenner, W. E., Corson, S. L., Kaiser, I. H., Kerenyi, T. D., King, T. M. and Tietze, C. (1976). Second trimester abortion—a symposium by correspondence. J. Reprod. Med., 16 (2), 47–64
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Copyright information
© 1990 The editors and contributors
About this chapter
Cite this chapter
Bygdeman, M. (1990). Abortifacient Drugs. In: O’Grady, J., Linet, O.I. (eds) Early Phase Drug Evaluation in Man. Palgrave, London. https://doi.org/10.1007/978-1-349-10705-6_40
Download citation
DOI: https://doi.org/10.1007/978-1-349-10705-6_40
Publisher Name: Palgrave, London
Print ISBN: 978-1-349-10707-0
Online ISBN: 978-1-349-10705-6
eBook Packages: EngineeringEngineering (R0)